Investors
Upcoming results
We will announce our first quarter 2024 results on Wednesday 1 May. Access our latest Quarterly results and Annual Report.
We’re confident in our future
With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.
Speeches and presentations
GSK dividend
GSK share price
Share price tool
Detailed information on GSK's share price, including an interactive chart
Innovation stories
‘Local innovation is vital to our mission to ensure no child is left to suffer from a vaccine preventable disease’
‘It is both a strategic and a moral imperative’: Why closing the health equity gap is better for everyone
‘Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk’
Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster
In the face of climate change, vaccines play a crucial but underestimated role
‘Adult vaccination plays an essential role in healthy ageing, so let’s prioritise prevention and make it a new standard of care’
A preventative patient-centred approach is key to transforming respiratory care and relieving struggling services
‘It can get very serious, very quickly’: the symptoms, risks, and ways to prevent pneumonia everyone should know about
'Prevention is the best medicine to stop disease before it starts'
Millions of people living with chronic hepatitis B are unaware they have the virus. So why aren’t they getting diagnosed?
![two scientists talking](/media/8490/stvg_03_2022_port_27_eagle_light.jpg?center=0.061666666666666668,0.955&mode=crop&quality=90&width=800&height=800&rnd=133020371800000000)